CONSIDERATIONS IN THE TREATMENT OF RETICULOENDOTHELIOSIS.
D000970:Antineoplastic Agents; D002648:Child; D004358:Drug Therapy; D004803:Eosinophilic Granuloma; D040181:Genetic Diseases, X-Linked; D006646:Histiocytosis, Langerhans-Cell; D006801:Humans; D007223:Infant; D007943:Leukemia, Hairy Cell; D008206:Lymphatic Diseases; D009369:Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy*; D011859:Radiography; D016511:Severe Combined Immunodeficiency; D013514:Surgical Procedures, Operative
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS; CHILD; DRUG THERAPY; EOSINOPHILIC GRANULOMA; HAND-SCHUELLER-CHRISTIAN SYNDROME; INFANT; LETTERER-SIWE DISEASE; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; RADIOGRAPHY; RETICULOENDOTHELIOSIS; SURGERY, OPERATIVE